Clinical Focus ›› 2015, Vol. 30 ›› Issue (11): 1251-1253.

Previous Articles     Next Articles

Low dose urokinase thrombolytic therapy for intermediate risk acute pulmonary thromboembolism

Jia Jianhou;Han Xinpeng   

  • Online:2015-11-05 Published:2015-11-05

Abstract: Objective To evaluate the efficacy and safety of low dose urokinase thrombolytic therapy for intermediate risk acute pulmonary thromboembolism. Methods Seventy-two medium risk of pulmonary thromboembolism patients were randomly divided into thrombolytic t

Key words: pulmonary embolism, urinary plasminogen activator, thrombolytic therapy

CLC Number: